Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
The proliferation of new psychoactive substances (NPS), including synthetic cannabinoids, is challenging regulatory systems and public health worldwide. Unlike conventional drugs, NPS often lack established safety profiles and pose unpredictable...